r Cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells are required to eliminate cancer cells.
r We analysed the Ca 2+ dependence of CTL and NK cell cytotoxicity and found that in particular CTLs have a very low optimum of [Ca 2+ ] i (between 122 and 334 nM) and [Ca 2+ ] o (between 23 and 625 μM) for efficient cancer cell elimination, well below blood plasma Ca 2+ levels.
r As predicted from these results, partial down-regulation of the Ca 2+ channel Orai1 in CTLs paradoxically increases perforin-dependent cancer cell killing.
r Lytic granule release at the immune synapse between CTLs and cancer cells has a Ca 2+ optimum compatible with this low Ca 2+ optimum for efficient cancer cell killing, whereas the Ca 2+ optimum for CTL migration is slightly higher and proliferation increases monotonously with increasing [Ca 2+ ] o .
r We propose that a partial inhibition of Ca 2+ signals by specific Orai1 blockers at submaximal concentrations could contribute to tumour elimination.
Introduction
Cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells kill their targets, virally infected or cancer cells, by several different mechanisms, the most prominent being the release of cytotoxic or lytic granules (LGs) containing perforin and granzymes at the immune synapse (IS) between cytotoxic cells and target cells. Already 40 years ago it was shown that cytotoxicity of CTLs is strongly dependent on Ca 2+ influx from the extracellular medium (Golstein & Smith, 1976; Plaut et al. 1976; Gately & Martz, 1977) . Ten years later it became clear that for granule exocytosis at the IS like exocytosis at neuronal synapses, a Ca 2+ -dependent step is required for CTL-induced cytotoxicity (Lancki et al. 1987; Takayama & Sitkovsky, 1987; Lyubchenko et al. 2001) . This further strengthened the analogy between these two types of synapses (Becherer et al. 2012 ) but raised the question of which channels would conduct the Ca 2+ currents required for vesicle fusion in the non-excitable cells of the haematopoietic system. With the identification of Ca 2+ release-activated Ca 2+ (CRAC) channels as the main source for Ca 2+ entry in mast cells and Jurkat T cells (Hoth & Penner, 1992 Zweifach & Lewis, 1993) , a valid hypothesis was that CTLs and NK cells also use CRAC channels as a Ca 2+ source to mediate LG release. Following the identification of CRAC channel-dependent Ca 2+ influx in CTLs during target cell engagement (Zweifach, 2000) and the identification of Orai1 as an essential component of endogenous CRAC channels (Feske et al. 2006; Vig et al. 2006; Zhang et al. 2006) , it was finally reported that Ca 2+ entry through Orai1 channels is required for LG exocytosis and target cell killing by primary human NK cells (Maul-Pavicic et al. 2011) .
Considering these findings, it is obvious that Ca 2+ influx through Orai1 channels is necessary to kill cancer cells (as reviewed in Schwarz et al. 2013) . The overall impact of Orai1 function on cancer progression is not determined only by its involvement in CTL and NK function, since Orai channels are also major players in proliferation, migration and metastasis of cancer cells (reviewed in Hoth, 2016; Iamshanova et al. 2017) . In many cancer types changes of expression levels and/or mutations of Orai channels and their activators, stromal interaction molecule (STIM) proteins, have been reported (Chen et al. 2011; Bergmeier et al. 2013; Vashisht et al. 2015) . While it is widely believed that Orai channel activity modulates cancer cell growth (Yang et al. 2009; Feng et al. 2010; Chen et al. 2011; Prevarskaya et al. 2011; Bergmeier et al. 2013; Vashisht et al. 2015; Xu et al. 2015; Hoth, 2016; Iamshanova et al. 2017) , mutations in Orai channels and other Ca 2+ channels are probably not causally linked to cancer development (Hoth, 2016) . However, considering the prominent role of Orai channels for cytotoxicity of CTLs and NK cells on one hand and for cancer growth on the other hand, Ca 2+ influx through Orai channels has at least a dual role in the tumour microenvironment. This makes Ca 2+ influx an interesting target to influence overall cancer growth. It is thus of relevance to understand if and how Ca 2+ determines the efficiency of human immune cell cytotoxicity against cancer cells. We have analysed the role of Ca 2+ for cancer cell elimination by primary human CTLs and NK cells, and we have investigated the potential underlying mechanisms.
Methods

Ethical approval
This research has been approved by the local ethic committee (84/15; Prof. Dr Rettig-Stürmer). Leukocyte reduction system (LRS) chambers, a byproduct of platelet collection from healthy donors, were kindly provided by the local blood bank in the Institute of Clinical Hemostaseology and Transfusion Medicine at Saarland University Medical Center. Prior to the sample being taken, blood donors provided written consent to use their blood for research purposes. The study conformed to the standards set by the Declaration of Helsinki, except for registration in a database.
Cells
Human peripheral blood mononuclear cells (PBMCs) of healthy donors were isolated from LRS chambers (Institute of Clinical Haematology and Transfusion Medicine, Homburg) by density gradient centrifugation using Lymphocyte Separation Medium 1077 (PromoCell, Heidelberg, Germany) . Primary human NK cells and CD8 + T cells were negatively isolated from PBMCs using Dynabeads Untouched Human NK Cells or T Cells Kits (11349D and 11348D, Thermo Fisher Scientific, Darmstadt, Germany) . Negative isolation avoids pre-stimulation of the isolated subtypes because antibody-coated beads against all other cell types are used for isolation and thus isolated subtypes do not come into contact with antibodies against any of their own plasma membrane proteins. Staphylococcal enterotoxin A (SEA)-stimulated CD8 + T cells were prepared as described before (Qu et al. 2011) . Briefly, positive isolation of CD8 + T cells was carried out following PBMC stimulation with 1 μg ml −1 SEA for 5 days and subsequent isolation by using Dynabeads CD8 Positive Isolation Kit (11333D, Thermo Fisher Scientific), which contains anti-CD8-coated beads. In the last step of the isolation process, anti-CD8-coated beads were removed from the cells by the DETACHaBEAD reagent (Thermo Fisher Scientific). PBMCs and isolated subtypes were maintained in AIM V medium (Thermo Fisher Scientific) supplemented with 10% fetal bovine serum (FBS). Jurkat T cells, Raji cells, P815 cells and K562 cells were maintained in RPMI 1640 medium (Thermo Fisher Scientific) supplemented with 10% FBS and 1% penicillin-streptomycin (Thermo Fisher Scientific). NK-92 cells were from DSMZ (Braunschweig, Germany) and cultivated in MEMα (Thermo Fisher Scientific) supplemented with 12.5% FBS (Thermo Fisher Scientific), 12.5% horse serum (Thermo Fisher Scientific), 2 mM L-glutamine (Sigma-Aldrich, Munich, Germany) and 10 ng ml −1 IL-2 (Thermo Fisher Scientific).
Reagents
Calcein-AM (C3100) and Fura-2/AM (F1211) were purchased from Thermo Fisher Scientific. Anti-CD3 (B-B11) antibody was from Diaclone (Besancon, France), lymphocyte function-associated antigen 1 (anti-LFA1) antibody (SM3100AS) was from Acris Antibodies (Herford, Germany). Anti-human CD28 (555725) was J Physiol 596.14 from BD Biosciences (Heidelberg, Germany). Fibronectin (F4759), phorbol 12-myristate 13-acetate (PMA, P1585), ionomycin (I0634), SEA (S9399) and EGTA (E4378) were from Sigma-Aldrich. All other chemicals and reagents not specifically mentioned were from Sigma-Aldrich.
Real-time killing assay
The real-time killing assay was carried out as previously described (Kummerow et al. 2014) . Briefly, cancer cells (Raji for CTL killing, K562 for NK/NK-92 killing) were loaded with 500 nM calcein-AM in AIM V medium containing 10 mM Hepes. Raji target cells were pulsed with 1 μg ml −1 SEA in AIM V medium for 30 min in the incubator before loading them with calcein-AM, and were then settled at 2.5 × 10 4 cells per well into the 96-well black plate with clear-bottom (353219, Corning, Amsterdam, Netherlands) . Primary NK cells, NK-92 or SEA-expanded CD8 + T cells were added subsequently onto cancer cells at the indicated effector to target ratio. Target lysis was measured either in an M200 Infinite plate reader (Tecan, Crailsheim, Germany) or a Genios Pro (Tecan) using bottom reading function at 37°C.
To study the impact of concanamycin A (CMA; Santa Cruz Biotechnology, Dallas, TX, USA) on cytotoxicity, NK cells or SEA-stimulated CTL were pre-incubated for 4 h in AIM V with 10% FBS and 10 mM Hepes containing 100 nM CMA (200 μM stock solution in dimethyl sulfoxide) at 37°C, 5% CO 2 at a density of 2 × 10 6 cells ml −1 . To exclude CMA effects on cancer cells, NK cells or CTLs were centrifuged and re-suspended in AIM V with 10% FBS with10 mM Hepes without CMA before measurement. Single cell Ca 2+ imaging was performed as previously described . To analyse Ca 2+ dynamics in cells, cells were loaded with 2 μM Fura-2/AM in FBS-free AIM V and were subsequently settled onto poly-D-ornithine-coated coverslips. Cells were monitored with an Olympus IX71 microscope equipped with an Olympus UPLSAPO ×20 (NA 0.75) objective and a camera controlled by TillVision software. Cells were excited at 340 and 380 nm with a polychrome V monochromator (T.I.L.L. Photonics, FEI Munich GmbH, Munich, Germany) using an ET Fura-2 filter set (Chroma Technology Corp., Rockingham, VT, USA). The emitted light at wavelength >400 nm (T400 LP dichroic beamsplitter, ET510/80 nm emission filter) was acquired ] i was determined according to the method described by Grynkiewicz et al. (1985) 
The K d was determined by a patch-clamp calibration, and R min , R max , S f2 and S b2 were determined from an in situ calibration in Jurkat T cells, which are used as a standard cell system to calibrate our set-ups. We have previously confirmed that Jurkat T cells and primary human T cells have very similar calibration values ).
Total internal reflection fluorescence microscopy imaging
Vesicle fusion was observed with a Leica DMI6000 B total internal reflection fluorescence (TIRF) MC microscope (Leica, Wetzlar, Germany). The emission line of a 561 nm solid state laser was used for excitation in TIRF mode and a Hamamatsu EMCCD 9100-02 camera (Hamamatsu, Japan) was used to acquire fluorescence images. Human anti-CD3/anti-CD28 bead-stimulated CTL overexpressing granzyme B-mCherry or perforin-mCherry were activated by an antibody cocktail of anti-CD3 (30 μg ml −1 ), anti-CD28 (90 μg ml −1 ) and anti-LFA1
(30 μg ml −1 ) coated onto the coverslip. Cells were settled onto the antibody-coated coverslips in modified Ringer solution with 0 mM [Ca 2+ ] o for 5 min. After one wash with fresh 0 mM [Ca 2+ ] o to flush away unsettled CTLs, images were acquired at indicated channels every 42 ms. Granzyme B-mCherry or perforin-mCherry overexpressing CTLs were monitored at 561 nm for LG fusion. After 20 s of acquisition, desired concentrations of [Ca 2+ ] o in AIM V medium were applied to the cells. LG fusion was analysed by ImageJ using the time series analyser 2.0 plugin. Vesicles were marked in regions of interest (ROIs) and the mean fluorescence intensity within ROIs was analysed over time.
CellTiter-Blue-based proliferation assay
The Ca 2+ dependence of CD8 + T cell proliferation was measured as described previously . Experiments were carried out as triplicates in 96-well plates (no. 353219, black/transparent bottom, Corning). For each data point 2.5 × 10 4 CTLs were seeded in a total volume of 200 μl in each well and cultured for 72 h at standard culture conditions in AIM V medium with 10% FBS. After 72 h, the numbers of living cells were determined by CellTiter-Blue (Promega (Madison, WI, USA)) following the manufacturer's instruction. Results are presented as percentage of relative fluorescence units (RFU). CTLs were stimulated with anti-CD3/anti-CD28-coated beads (no. 111.32D, Dynabeads Human T-Activator CD3/CD28, Thermo Fisher Scientific) at a ratio of 1:1 (bead/cell). To analyse cell proliferation under limiting Ca 2+ conditions, 0.8-4 mM EGTA (from the 100 mM stock solution in H 2 O, pH 8.0, sterile filtered) was added in a total volume of 100 μl into the plates to partially chelate Ca 2+ (see above for details). To investigate cell proliferation under elevated Ca 2+ conditions, 2-8 mM CaCl 2 (from the 1 M stock solution in H 2 O, sterile filtered) was added into the medium. To equilibrate pH, plates were pre-incubated for at least 2 h at 37°C, 5% CO 2 and 95% humidity before CTLs were mixed with antibody-coated beads and applied in a total volume of 100 μl. Proliferation was measured with the plate reader Genios Pro (Tecan) using the bottom reading function at 37°C.
Electroporation
SEA stimulated CTLs were transfected as described earlier (Bhat et al. 2016) . Briefly, for the siRNA transfection, 100 μl cell suspension was nucleofected with 8-10 μl (20 μM stock solution) or 4 μl (40 μM stock solution) of the following siRNA stock solutions: FlexiTube GeneSolution GS5551 for perforin 1 (Qiagen, Hs PRF1 1, 3, 4 and 5, pool, 2.5 μl each), Orai1 1 and Orai1 2 (Qiagen, Hilden, Germany, no. SI03196207 and no. SI04215316, modified, 5 μl each) and various control siRNAs, AllStars negative control siRNA (Qiagen, no. 1027280, 20 μM), negative control siRNA (Qiagen, no. 1027310, 20 μM, unmodified and modified), control siRNA (Microsynth, Balgach, Switzerland, 40 μM, modified). Modifications were introduced according to Mantei et al. (2008) by Microsynth. Twelve to sixteen hours following siRNA transfection, cells were washed and plated at 1.5 × 10 6 cells ml
in fresh AIM V plus 10% FBS media with 20 μg ml
IL-2 added and incubated until further use (36-44 h for perforin or 1 and 3 days for Orai1-transfected CTLs). For the protein over-expression, 100 μl cell suspension of anti-CD3/anti-CD28 bead-stimulated CTLs was nucleofected with 0.5 μg granzyme B-mCherry construct or 0.75 μg perforin-mCherry construct using the 4D Nucleofector system from Lonza (Cologne, Germany). The medium was replaced 6 h post transfection and cells were used 15-24 h after the transfection. Modified primer sequences are identical as previously published (Holzmann et al. 2013 
RNA isolation and qRT-PCR
Experiments were carried out as described before (Wenning et al. 2011) . In brief, total RNA was isolated from 1.5 × 10 6 SEA-stimulated CTLs using TRIzol reagent (Thermo Fisher Scientific) supplemented with 1 μl glycogen (5 μg μl −1 , Thermo Fisher Scientific). Total RNA (0.8 μg) was reverse transcribed and 1 μl of cDNA was used for quantitative real-time polymerase chain reaction (qRT-PCR). Real-time PCR was carried out in a CFX96 Real-Time System C1000 Thermal Cycler (Bio-Rad Laboratories, Munich, Germany) (software: Bio-Rad CFX Manager, Version 3.0) as described before (Wenning et al. 2011) . Primer sequences for reference genes RNAPolII (accession NM 000937) and TBP (accession NM 003194) and for Orai1 are taken from (Wenning et al. 2011) , and for perforin from (Bhat et al. 2016) .
Migration
The observable area of an Ibidi (Martinsried, Germany) cell culture μ-dish (81156) was coated with 100 μl bovine fibronectin (Sigma-Aldrich, F4759) solution with a concentration of 0.1 mg ml −1 (stock solution at 1 mg ml −1 in distilled H 2 O, dilution to 0.1 mg ml −1 in PBS) and allowed to dry for 45 min at room temperature under a sterile bench. Remaining fibronectin was then removed with a cell culture aspirator. SEA-stimulated CTLs (1 × 10 4 ) were seeded in AIM V medium with 10% FBS and incubated at 37°C for 1 h. Medium was then replaced by buffer solutions containing 155 mM NaCl, 4.5 mM KCl, 10 mM glucose, 5 mM Hepes and variable concentrations of CaCl 2 . In the case of the Ca 2+ -free buffer, 1 mM EGTA was added. Imaging was performed at 37°C on a Zeiss Cell Observer HS with an AxioCam MRm camera (Carl Zeiss Microscopy, Jena, Germany) and a Fluar ×5/0.25 objective in brightfield mode at 6 frames min −1 . The cells were slightly defocused to facilitate subsequent tracking. Cell tracking was performed in ImageJ 1.46r using a combination of automatic tracking with MTrack2 (https://valelab4. ucsf.edu/˜nstuurman/IJplugins/MTrack2.html by N. Stuurman (2003) , MTrack2, retrieved 6 September 2017) and manual correction with Speckle Tracker (Smith et al. 2011) . Quantification of the obtained trajectories was done in Igor Pro 6.31.
The displacement r(t, t) is the distance between the centroid of a cell at time t and a time t + t, r(t, t) = |r(t + t) − r(t)|, where r(t) is the position vector of a centroid at time t. The instantaneous velocity v(t) is given by v(t) = (r(t + t) − r(t))/ t, where δt is the time between two successive frames. From these quantities, the mean-squared displacement is given by MSD( t) = r (t, t) 2 and the velocity autocorrelation is given by VAC( t) = v(t) · v(t + t) . In both cases, brackets indicate averages with respect to the cells in a batch. Within experimental error, the velocity autocorrelation is independent of the time t and thus the VAC will be averaged also over a sliding window for the reference time t. The velocity distributions shown have been obtained after averaging the tracks using a sliding window.
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Statistical analysis
Data are presented as the mean ± SEM (n = number of experiments) if not stated otherwise. Data were tested for significance using one-way ANOVA or Student's t test (if Gaussian distribution was confirmed):
* P < 0.05, * * P < 0.01, * * * P < 0.001; ns, no significant difference. Statistics were calculated using Microsoft Excel 2010, Igor Pro6 or Prism 7 (GraphPad Software, La Jolla, CA, USA) software.
Killing assays in Figs 1 and 2 were analysed as described before (Kummerow et al. 2014) . Killing assays for CTLs, primary NK or NK-92 cells were assumed as appropriate when the proportionality factor r was 0.8 < r < 1.2 (r = F live (0)/F exp (0), where F live is fluorescence of target cells only, and F exp is fluorescence of the wells with target and effector cells). Out of all killing experiments performed in this publication, only four single experiments with CTLs and none from primary NK or NK-92 cells did not meet this criterion and were thus not included in the analysis.
Results
Ca
2+ dependence of perforin-dependent
CTL cytotoxicity
To quantify perforin-dependent cytotoxicity of primary human CTLs and NK cells, we used a real-time cytotoxicity assay (Kummerow et al. 2014) . For CTLs, staphylococcal enterotoxin A (SEA)-pulsed Raji cells were used as target (cancer) cells. Figure 1A shows the kinetics of cancer cell killing by primary human CTLs (blue curve). Quantification of maximum killing rates in two time periods (0-60 and 61-240 min) reveals that the killing efficiency is higher during the first hour compared to the next 3 h (Ctrl-siRNA in Fig. 1A and B) . The two major cytotoxic mechanisms of CTLs are based on perforin/granzyme or the Fas/FasL system (Henkart, 1994) . To assess the contribution of the perforin/granzyme system on CTL cytotoxicity, perforin mRNA levels were down-regulated by a pool of siRNAs against perforin to about 50% of control levels as confirmed by qRT-PCR relative to control siRNA-transfected CTLs normalized to the reference genes, TBP and RNAPol. Down-regulation of perforin was paralleled by a clear reduction of the cytotoxic efficiency of CTLs against cancer cells (Fig. 1A , PRF-siRNA, red curve). Maximum killing rates and in particular the maximal rate during the first 60 min are reduced to about 40% of control (Fig. 1B) . Considering the significant killing rate reduction during the first 60 min following perforin down-regulation, we conclude that a majority of cancer cells are killed during the first 60 min in a perforin-dependent way. The imperfect down-regulation by the perforin siRNA to only 50%
suggests that the role of perforin in CTL killing is even more pronounced than determined with this type of assay.
To further test the importance of perforin, we used concanamycin A (CMA), which has been reported to inhibit perforin function by disrupting the pH value within LGs (Kataoka et al. 1996) without interfering with the Fas/FasL system at the low concentration used here (100 nM). Figure 1C shows that CMA almost completely abolished cancer cell killing by CTLs compared to control conditions. Quantification of the rates reveals that CMA reduced the maximal killing rate during the first 60 min to about 11% of control (Fig. 1D) . Thus we conclude that, in our experimental setting, CTLs kill the majority of cancer cells during the first 60 min in a perforin-dependent manner.
IS formation between CTLs and Raji cells activates Ca 2+ entry through Orai channels and Ca 2+ entry has been shown to be important for CTL cytotoxicity mediated by perforin and granzyme release from LGs (Lyubchenko et al. 2001; Maul-Pavicic et al. 2011 (Fig. 1F) . Quantification of cancer cell killing reveals that target lysis is very low at very low [Ca 2+ ] o (3-6 μM) and increases up to a value of 384 μM (Fig. 1G) . Surprisingly the killing efficiency dropped at higher [Ca 2+ ] o , which is most evident at the highest [Ca 2+ ] o of 2593 or 4858 μM ( Fig. 1F and G) . Averaging all experiments shows that CTLs work most efficiently against cancer cells at relatively low [Ca 2+ ] o in the range between 23 and 625 μM (Fig. 1G) Fig. 1J , showing a strictly monotonously rising function as expected, which could be fitted by an exponential function. This function was used to calculate cancer cell lysis as a function of Fura-2 ratios (340/380) (Fig. 1K) (Lanier, 2005; Guillerey et al. 2016) . A standard target for primary human NK cells is K562 cells or Jurkat T cells (Langhans et al. 2005) , which are both killed very efficiently as measured by the real-time killing assay ( Fig. 2A and C, blue curves). NK cells kill very fast within the first 60 min and quantification of killing rates revealed that the killing efficiency is much higher during the first 60 min compared to the next 3 h (compare blue bars in Fig. 2B and D) . The difference between the two targets is that Jurkat T cells can be killed by both LGs (containing perforin and granzyme) and Fas/FasL-dependent pathways, whereas K562 can only be killed by LGs but not by Fas/FasL because they lack the Fas receptor (Owen-Schaub et al. 1995) . Primary human NK cells cannot easily be transfected and thus we relied on only CMA to test the contribution of perforin-dependent cancer cell killing rather than perforin down-regulation as used for CTLs. Figure 2A and B show that CMA almost completely blocked K562 cell killing by NK cells compared to control conditions. In particular the maximal rate during the first 60 min was reduced from 16%/10 min to 1.5%/10 min. For Jurkat T cells, the results during the first 60 min were identical (reduced from 15% to 1.3%/10 min), but at later time points significant killing occurred ( Fig. 2C and D) , indicating that Fas/FasL was still working properly between NK and Jurkat T cells.
From both sets of experiments we conclude that more than 90% of the initial killing by NK cells during the first 60 min is perforin dependent, very similar to CTLs. For K562 cells, close to 100% should theoretically be killed in a perforin-dependent manner because they lack the Fas receptor (Owen-Schaub et al. 1995) . In conclusion, the killing assay used in this study reports mostly perforin dependent cancer cell death following target cell encounter with either CTLs or NK cells. To test the Ca 2+ dependence of perforin-mediated NK cytotoxicity against cancer cells, we used primary human NK cells and also NK-92 cells, a well-established human NK cell line (Klingemann et al. 2016) . As targets we used K562 cells because they cannot be killed by Fas/FasL. As for CTLs, [Ca 2+ ] o was varied in AIM V by adding either EGTA or CaCl 2 (Fig. 1E-H) . Similarly to CTLs, NK or NK-92 cell cytotoxicity against cancer cells is very low at very low [Ca 2+ ] o (3-15 μM; Fig. 2E-H) . Optimal NK or NK-92 cytotoxicity is observed at [Ca 2+ ] o between 384 and 800 μM ( Fig. 2F and H) . In primary NK cells, cytotoxicity does not drop much at higher [Ca 2+ ] o (Fig. 2F ), whereas this effect is slightly more pronounced in NK-92 cells (Fig. 2H) .
As for CTLs, [Ca 2+ ] i measured as the Fura-2 ratio (340/380) was determined as a function of [Ca 2+ ] o by Ca 2+ imaging experiments of NK-92 cells in contact with K562 cells (Fig. 2I) . The correlation between the Fura-2 ratio and [Ca 2+ ] o is presented in Fig. 2J , showing a strictly monotonously rising function as expected, which could be fitted by a Hill function. This function was used to calculate the cancer cell lysis as a function of the Fura-2 ratio in NK-92 cells (Fig. 2K) . As expected from the dependence of cytotoxic efficiency on [Ca 2+ ] o , the dependence on the Fura-2 ratio also showed an optimum. This optimum is at a Fura-2 ratio of about 1.0 with a decline for lower and higher ratios.
Orai1 down-regulation increases perforinmediated killing
The free [Ca 2+ ] o in blood plasma is around 1200 μM (total Ca 2+ around 2400 μM). In the tumour microenvironment, free [Ca 2+ ] o is not known. Considering the relatively low Ca 2+ optimum of CTL cytotoxicity, our data predict that under certain conditions a reduction of Orai1 expression (or Orai1 inhibition) should not decrease but rather increase the perforin-dependent killing efficiency of cancer cells by CTLs.
We down-regulated Orai1 in primary human CTLs using an siRNA approach. Effective down-regulation is shown in the mRNA level (Fig. 3A) . As expected, Orai1 down-regulation decreased [Ca 2+ ] i signals in CTLs by about 50% following store depletion by thapsigargin (Fig. 3B-D) or following stimulation with SEA antigen-presenting cells (Fig. 3E) . In parallel experiments we tested the killing efficiency of CTLs (Fig. 3F) from the same blood donors as shown in Fig. 3E . The killing efficiency was analysed with AIM V medium containing 800 μM free [Ca 2+ ] o , which is above the range optimal for CTL cytotoxicity (23-625 μM) . Figure 3F shows that, as predicted from the Ca 2+ dependence described in Fig. 1K and L, a decrease in Orai1 expression and Orai1-dependent Ca 2+ signals correlated with an increase in killing efficiency under these conditions ( Fig. 3F and G) . The overall cancer cell lysis and in particular the maximal killing rate of cancer cells were significantly enhanced in Orai1 down-regulated CTLs (Fig. 3G) . We conclude that cancer cell lysis by CTLs can be increased by a decrease of Orai1 activity.
Mechanisms to tune Ca 2+ -dependent CTL cytotoxicity
There are several steps during the CTL-mediated killing process of cancer cells which could confer the Ca E, Ca 2+ influx of CTLs upon target recognition 70 h after the transfection with control siRNAs (Ctrl1 (dark grey) or Ctrl2 (light grey)) and Orai1 siRNA (red); 2 × 10 5 CTLs were loaded with 2 μM Fura-2/AM and settled on the coverslip in modified Ringer solution containing 0 mM Ca 2+ . Images were acquired every 5 s at both 340 nm and 380 nm excitation (n = 21 cells Orai1 siRNA, n = 44 cells Ctrl1; n = 74 cells Ctrl2). F, real-time killing assay with SEA-pulsed Raji cells as target cells with an E:T ratio of 20:1. CTLs were transfected with Orai1 siRNA (red) or control siRNA (dark grey). Data are from 4 donors (n = 8 independent experiments for two different Ctrl siRNA; n = 4 for Orai1 siRNA). G, statistical analysis of the maximal killing rate from data is shown in F.
J Physiol 596.14 ( Fig. 1G) . In principle, Ca 2+ -dependent CTL proliferation, migration, LG accumulation at the IS and/or LG release at the IS could determine the Ca 2+ optimum. We tested these possibilities.
Proliferation. Considering that we only analysed target cell killing over 4 h, it appears unlikely that proliferation was responsible for the Ca 2+ optimum of CTL cytotoxicity. Nevertheless we analysed the [Ca 2+ ] o dependence of CTL proliferation. In contrast to the Ca 2+ dependence of cytotoxicity with a [Ca 2+ ] o optimum between 23 and 625 μM in AIM V medium, CTL proliferation showed no detectable [Ca 2+ ] o optimum. Non-stimulated CTLs (Fig. 4, naïve, grey circles) did not proliferate much, whereas CTL stimulation with anti-CD3/anti-CD28-coated beads resulted in a monotonously increasing proliferation with increasing [Ca 2+ ] o but without a maximum (Fig. 4 , red and blue circles). EGTA was not toxic, as CTLs in AIM V medium supplemented with equal amounts (1.0 mM or 1.5 mM) EGTA and Ca 2+ proliferated similarly to those without additional EGTA and Ca 2+ (Fig. 4 , green circles).
Migration. One could argue that there are too many CTLs per well and thus migration does not play a role in this assay. However, the majority of SEA-stimulated CTLs usually kill inefficiently, and thus migration of the 'competent' killers may be of importance. To study CTL migration at different [Ca 2+ ] o , we used time-lapse microscopy. On a short time scale (seconds or minutes), CTLs show directional persistence, whereas migration on a long time scale (minutes or hours) is random. Representation of random migration tracks starting at the same origin are shown in the absence of extracellular Ca 2+ (0 mM [Ca 2+ ] o ) or in the presence of 1 mM [Ca 2+ ] o (Fig. 5A ). It is immediately obvious that CTLs can still migrate without any [Ca 2+ ] o present (1 mM EGTA was added), at least during the investigated time of 1 h, which was quite surprising to us. We speculate that acute removal of [Ca 2+ ] o does not completely inhibit migration due to residual Ca 2+ contained in the intracellular stores of CTLs. The distance travelled under this condition is, however, shorter. This is also evident by the analysis of the mean square displacement (MSD) in 0 mM and 1 mM [Ca 2+ ] o (Fig. 5B) .
To analyse the Ca 2+ dependence of migration in more detail, we carried out experiments as the ones shown in Fig. 5A Fig. 5D . The velocity autocorrelation function is a measure for how long a cell's direction of motion persists. It typically falls off exponentially where τ is the persistence time. The analysis reveals that persistence time (Fig. 5E ) and persistence displacement (Fig. 5F) LG accumulation at the IS. Granzyme B-mCherry was transiently transfected into CTLs to label LGs. TIRF microscopy was used to count LGs at the IS formed between the antibody-coated surface of the glass and the cell as previously reported (Qu et al. 2011) . Figure 6A shows an example of LGs located at the IS for three different [Ca 2+ ] o (3, 146 and 800 μM) which are below, in between or above the optimal [Ca 2+ ] o range of 23-625 μM for CTL cytotoxicity. The data are quantified in Fig. 6B . At 146 μM [Ca 2+ ] o (grey curve) about 13
LGs are present at the IS. This number is increased at higher and lower [Ca 2+ ] o . Two possibilities may explain this result: at 146 μM [Ca 2+ ] o (1) more LGs were released, or (2) fewer LGs were recruited to the IS. The latter would not explain the phenotype that CTLs kill very well at 146 μM.
LG release at the IS. Considering the reduction of LGs at the IS at 146 μM, it is reasonable to assume that more LGs are released at the IS under these conditions. We tested this hypothesis by TIRF microscopy under the same conditions as described above. Figure 6C shows three images of LGs in a CTL stained by granzyme B-mCherry. The fluorescence signal of each individual LG was recorded over time with fastest possible acquisition (one image every 42 ms). Fluorescence changes of each LG were analysed as shown in Fig. 6C and D. Release of
LGs is evident by a sharp drop of fluorescence usually preceded by a very brief increase of fluorescence due to neutral pH-induced higher fluorescence of mCherry during fusion (Liu et al. 2011) . For the LG marked with a red circle in Fig. 6C , a sharp drop of fluorescence signal kinetics within 42 ms was observed indicating that it was released (Fig. 6D) , whereas other LGs showed more constant fluorescence signals, indicating either moving or stationary LGs (Fig. 6D) 
Discussion
A pro-oncogenic tumour microenvironment is one key factor for uncontrolled tumour growth. The immune system is in principle well positioned to control and eliminate tumour cells. However, if the immune system is not fast enough, the tumour has the potential to develop measures to mask itself, or even worse, may hijack the immune system for its own purposes (Hanahan & Weinberg, 2011) . It is clear that the efficiency of tumour elimination in its early stages is a key factor for a successful immune response. Many metabolic factors, hormones or messengers influence the tumour-immune microenvironment, Ca 2+ being one of them. Ca 2+ is a central factor for cell proliferation and it is thus no surprise that many studies have provided good evidence that Ca 2+ channels are upregulated in cancerous tissues. The rationale behind this is that more Ca 2+ channels willslightly -increase the cellular Ca 2+ concentration and thereby increase or modulate cancer cell proliferation, invasion, migration and metastasis. This is also true for the CRAC channel components STIM and Orai (Yang et al. 2009; Feng et al. 2010; Chen et al. 2011; Prevarskaya et al. 2011; Bergmeier et al. 2013; Vashisht et al. 2015; Xu et al. 2015; Hoth, 2016; Iamshanova et al. 2017) . It should, however, be noted, that CRAC channel genes J Physiol 596.14 cannot be considered cancer drivers but rather passengers considering cancer genome analyses as discussed in Hoth (2016) . Nevertheless inhibiting Ca 2+ influx into tumour cells should slow down their proliferation rate.
This benefit should, however, come at the cost of reduced cytotoxic functionality of human CTLs and NK cells as evident by the necessity of Orai1 activity for cytolytic immune cell functions as clearly shown by Maul-Pavicic et al. (2011) and Klemann et al. (2017) . Thus, it is widely believed that the benefit of inhibiting CRAC/Orai activity to reduce tumour growth will be counteracted by a reduced eradication of cancer cells through CTLs and NK cells. Considering these results it seems questionable if inhibition of CRAC/Orai-dependent Ca 2+ entry into CTLs and NK cells could be a therapeutic option in a multimodal cancer therapy as proposed by many groups from the Ca 2+ signalling field (Yang et al. 2009; Feng et al. 2010; Chen et al. 2011; Prevarskaya et al. 2011; Bergmeier et al. 2013; Vashisht et al. 2015; Xu et al. 2015) .
The results of the present study point in another direction. The finding that CTLs and NK cells have an (Voskoboinik et al. 2005) . In addition, this reduction could also be explained by our finding that below 23 μM [Ca 2+ ] o LG release is impaired.
While the importance of Orai1/CRAC channel activity for cytolytic immune cell functions has been convincingly demonstrated (Lyubchenko et al. 2001; Maul-Pavicic et al. 2011; Schwarz et al. 2013; Klemann et al. 2017) , there are several reports that cytotoxicity is only slightly reduced in tumour-specific murine CTLs following a drastic reduction of Ca 2+ signals by the application of 1 μM BTP2 , one of the most potent CRAC channel blockers (Zitt et al. 2004) . In murine NK cells, it was recently reported that degranulation was persisting in the complete absence of Ca 2+ (Freund-Brown et al. 2017 ). This finding was based on in vivo data in STIM1/2 double knock-out NK cells and on in vitro data in the absence of [Ca 2+ ] o . Our data may reconcile these different findings. The very low Ca 2+ optimum for CTL and NK cell cytotoxicity (between 122 and 334 nM for [Ca 2+ ] i and between 23 and 625 μM for [Ca 2+ ] o in case of CTLs) indicates that Ca 2+ influx can probably be reduced dramatically but still allow very good perforin-dependent cytotoxicity. Considering this, we would like to point out the problem of controlling [Ca 2+ ] o in external cell culture media. We needed, in the range of 1 mM EGTA, to reduce [Ca 2+ ] o to very low micromolar levels in AIM V medium with no FBS added. FBS in our experiments added a large amount of Ca 2+ and we therefore chose to leave it out. In the experimental set-up used by (Freund-Brown et al. 2017) , FBS was added together with 250 μM EGTA to Ca 2+ -free medium (S-MEM). Depending on the Ca 2+ concentration in FBS, 250 μM may not be sufficient to reduce [Ca 2+ ] o to very low micromolar levels. Considering our findings, we expect that under these circumstances, NK cells would maintain significant degranulation and killing capacity as observed in the study. We therefore question the conclusion that store-operated Ca 2+ entry is not required for NK cell degranulation and perforin-dependent cytotoxicity. A Ca 2+ optimum at very low Ca 2+ entry, on the other hand, is in good agreement with the other published data sets (Lyubchenko et al. 2001; Maul-Pavicic et al. 2011; Weidinger et al. 2013; Klemann et al. 2017) .
The reason for the unexpected low cytotoxic Ca 2+ optimum of CTLs and NK cells is probably related to the Ca 2+ optimum for LG release at the IS, which is in the same range as the cytotoxic efficiency against target cells. However, there is an apparent inconsistency. Whereas at 800 μM [Ca 2+ ] o , LG release is significantly reduced in CTLs, the overall global killing is only slightly affected. This inconsistency could in principle be explained as follows. (1) The relationship between LGs and killing efficiency could be non-linear, as are many biological correlations. (2) The CTL population is heterogeneous, which means that some cells kill very efficiently and others do not (Vanherberghen et al. 2013) . (3) The efficiency of target cell killing depends on several Ca 2+ -dependent mechanisms, which is the case in CTLs as also shown in the present paper. CTL migration (velocity and persistence) have a maximum at 500-1000 μM [Ca 2+ ] o . As both processes, LG release and migration, likely contribute to the efficiency of target cell killing, it is reasonable that the Ca 2+ optimum for target cell killing is higher than the optimum of LG release.
The [Ca 2+ ] o optimal for cancer cell killing (between 23 and 625 μM) is far below the normal concentrations in blood plasma (1.2 mM). While it is intriguing to speculate on the effect of hyper-or hypocalcaemia on immune cell killing, it is unlikely that blood plasma [Ca 2+ ] could vary so much as to be relevant for killer cell function: free [Ca 2+ ] is tightly regulated and levels below 1.1 mM are already considered as severe hypocalcaemia with heavy generalized symptoms such as neuro-muscular dysfunction (tetany, seizures). We do, however, believe that [Ca 2+ ] o in the extracellular space of different tissues could vary to such a degree, considering, for example, that tumours are densely populated by malignant cells, stroma and infiltrating lymphocytes while vascularization and thus perfusion is often very limited.
One disadvantage of our measurement is that we have only analysed global [Ca 2+ ] i signals. In CD4 + T cells, local Ca 2+ signals at the IS are very inhomogeneous (Quintana et al. 2011 ) and it has been recently shown that targeted Ca 2+ entry in CTLs increases cytotoxic functions against tumour cells (Kim et al. 2017) . Thus, to fully understand the Ca 2+ dependence of LG release in CTLs and NK cells, local domains at the IS have to be analysed and potential Ca 2+ sensors need to be identified. A potential candidate is synaptotagmin VII, which is expressed in murine CTLs and probably regulates Ca 2+ -dependent LG exocytosis (Fowler et al. 2007) . Interestingly, local Ca 2+ domains are also very important to selectively activate different isoforms of the transcription factor nuclear factor of activated T cells (NFAT; Kar & Parekh, 2015; Kar et al. 2016) , which are key transcription factors in T cells. One of these, NFATc1, has recently been shown to control cytotoxicity of murine CTLs (Klein-Hessling et al. 2017) . Thus, there is another highly relevant Ca 2+ -dependent process 
